Please assess the completion status of the following clinical trial:

Trial Title: Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥18 years of age~* full term (≥37 weeks) gestations determined by routine obstetrical guidelines~* singleton gestation in cephalic presentation~* Both nulliparous and multiparous women~* Intact membranes~* Bishop score of ≤6 and cervical dilation ≤2cm~Exclusion Criteria:~* Any contraindication to a vaginal delivery or to misoprostol~* fetal demise~* Multifetal gestation~* major fetal anomaly~* prior uterine surgery, previous cesarean section~* women with HIV, hepatitis C, hepatitis B, and women with medical conditions requiring an assisted second stage~* Additional exclusion criteria were as follows: category 3 fetal heart rate tracing, hemolysis elevated liver enzymes and low platelets (HELLP) syndrome or eclampsia, growth restriction \<10th percentile (based on Hadlock growth curves) with reversal of flow in umbilical artery Doppler studies, and growth restriction \<5th percentile with elevated, absent, or reversal of flow in umbilical artery Doppler studies.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Early Amniotomy (Type: ACTIVE_COMPARATOR): Women in the Early AROM group will under amniotomy one hour from Foley Catheter expulsion. Labor augmentation will continue per study protocol. Refer to Appendix A for protocol regimen.
- Delayed Amniotomy (Type: ACTIVE_COMPARATOR): Women in the Delayed AROM group will undergo amniotomy at the discretion of the obstetrician or labor provider. No specific instructions will be given.

Based on this trial design, predict the completion outcome and termination type (if applicable).